AHR and metabolic dysfunction-associated steatotic liver disease: It has been demonstrated that microbiota-derived tryptophan metabolites, such as indole-3-acetate, tryptamine, and indole-3-carbinol, can reduce the pathology of NAFLD through the aryl hydrocarbon receptor (AHR) pathway [51,52].